Clinical Trial Update: Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores [Phase 2]

View source ↗

Summary

Phase 2 trial update on topical ZEP-3 1.0% ointment for herpes labialis shows safety, tolerability, and therapeutic efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Labialis

Drugs mentioned

• ZEP-3 Ointment (ZEP-3)

Snippet

Sponsor: Shulov Innovate for Science Ltd. 2012 | Conditions: Herpes Labialis | Phase 2 | Status: COMPLETED